PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.60%
Revenue growth at 75-90% of RUN's 18.13%. Bill Ackman would push for innovation or market expansion to catch up.
-4711.83%
Negative gross profit growth while RUN is at 92.40%. Joel Greenblatt would examine cost competitiveness or demand decline.
-274.31%
Negative EBIT growth while RUN is at 38.34%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-256.54%
Negative operating income growth while RUN is at 38.34%. Joel Greenblatt would press for urgent turnaround measures.
-285.53%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-281.93%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-281.93%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.51%
Share reduction more than 1.5x RUN's 1.96%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.51%
Diluted share reduction more than 1.5x RUN's 5.67%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
47.66%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
42.53%
Positive FCF growth while RUN is negative. John Neff would see a strong competitive edge in net cash generation.
-33.88%
Negative 10Y revenue/share CAGR while RUN stands at 137.56%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-33.15%
Negative 5Y CAGR while RUN stands at 137.56%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
12.39%
3Y revenue/share CAGR under 50% of RUN's 107.66%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-329.39%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-58.31%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
45.10%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
-908.65%
Negative 10Y net income/share CAGR while RUN is at 131.11%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-2061.24%
Negative 5Y net income/share CAGR while RUN is 131.11%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-6649.94%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-97.97%
Negative equity/share CAGR over 10 years while RUN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-96.88%
Negative 5Y equity/share growth while RUN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-97.83%
Negative 3Y equity/share growth while RUN is at 146.70%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3.38%
AR growth well above RUN's 1.01%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.89%
We show growth while RUN is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-18.85%
Negative asset growth while RUN invests at 4.83%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-75.77%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-16.71%
We’re deleveraging while RUN stands at 15.36%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
65.82%
R&D growth drastically higher vs. RUN's 29.67%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-0.34%
We cut SG&A while RUN invests at 0.51%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.